WELLINGTON MANAGEMENT GROUP LLP
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 902219
Boston, MA
Position in REGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$791,950,042
-$627,744,276 QoQ
Shares Held
1,270,087
-30.9% QoQ
Ownership
1.23%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#15
of 1,322 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 98%
None 2%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLINGTON MANAGEMENT GROUP LLP holds $14,994,233,945 across 206 Biotechnology names. REGN ranks #3 (5.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,247,658 | $1,613,209,155 | |
| 2 | ARGX |
Argenx SE
|
930,548 | $863,334,513 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
1,270,087 | $791,950,042 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,843,415 | $719,794,757 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,110,407 | $635,295,816 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
7,651,415 | $606,680,693 | |
| 7 | CYTK |
Cytokinetics Inc
|
6,931,770 | $590,517,483 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
825,714 | $443,367,129 |
All Filings in REGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $791,950,042 | 1,270,087 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,419,694,318 | 1,837,459 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $512,880,595 | 664,465 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $4,284,496 | 7,620 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $37,356,375 | 71,155 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $11,044,479 | 17,414 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $106,015,358 | 148,829 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $463,185,801 | 440,609 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,115,974,190 | 1,061,791 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,051,977,502 | 1,092,975 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $967,954,622 | 1,102,090 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $1,240,106,076 | 1,506,885 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,199,194,395 | 1,668,932 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,452,646,001 | 1,767,919 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $1,743,298,044 | 2,416,247 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $1,683,108,490 | 2,443,289 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,408,631,456 | 2,382,947 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $2,018,575,575 | 2,890,203 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,979,673,103 | 3,134,775 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $2,038,285,572 | 3,368,065 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $2,266,210,138 | 4,057,382 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $1,834,070,428 | 3,876,380 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $1,753,941,477 | 3,630,522 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $1,947,209,841 | 3,478,527 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $2,284,971,273 | 3,663,868 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $1,004,294,849 | 2,056,759 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||